Artemis Live - Insurance-linked securities (ILS), catastrophe bonds (cat bonds), reinsurance 13: Matt Jones, Anthemis, May 2020 - talking insurtech (insurance & reinsurance technology) startups
Jun 16, 2020
30:10
Matt Jones, Principal at financial technology (fintech), insurance or reinsurance technology (insurtech) venture capital investment firm Anthemis joined us for our latest video interview.
Jones talked about the venture investing thesis at Anthemis, the sectors of fintech and insurtech that excite the company, as well as his views on the insurtech wave that has spread across insurance and reinsurance markets in recent years.
"If I think about the investment thesis we've got... within the insurance industry everything is in scope, at least at this point. We still feel that there are sufficient opportunities across pretty much all lines of business, whether it's P&C, life and health, primary or reinsurance and across the entire value-chain," Jones explained.
"We're also investing in a series of other spaces that we call adjacencies. These are where there are opportunities to embed financial products, or insurance products, into other industries and where you can see other businesses being built that could have a knock-on impact on the insurance industry further down the line," he continued.
He discussed trends in insurtech, both before and now through the lens of the Covid-19 pandemic, as well as where Anthemis sees opportunities going forwards.
On the potential for the capital markets and insurance-linked securities (ILS) funds to work alongside insurtech start-ups, Jones sees companies looking to efficiency, in terms of capital and reinsurance capacity.
Jones said, "One of the things we see our start-ups spending a lot of time thinking through, is what is the most efficient form of capital that I should be working with, or the best form of capital.
"Is it the reciprocal model, is it traditional reinsurance, is it having their own carrier. You know, is it doing something using derivatives in Bermuda, for example. For each start-up there's going to be an ideal answer, I think."
Jones talked about the venture investing thesis at Anthemis, the sectors of fintech and insurtech that excite the company, as well as his views on the insurtech wave that has spread across insurance and reinsurance markets in recent years.
"If I think about the investment thesis we've got... within the insurance industry everything is in scope, at least at this point. We still feel that there are sufficient opportunities across pretty much all lines of business, whether it's P&C, life and health, primary or reinsurance and across the entire value-chain," Jones explained.
"We're also investing in a series of other spaces that we call adjacencies. These are where there are opportunities to embed financial products, or insurance products, into other industries and where you can see other businesses being built that could have a knock-on impact on the insurance industry further down the line," he continued.
He discussed trends in insurtech, both before and now through the lens of the Covid-19 pandemic, as well as where Anthemis sees opportunities going forwards.
On the potential for the capital markets and insurance-linked securities (ILS) funds to work alongside insurtech start-ups, Jones sees companies looking to efficiency, in terms of capital and reinsurance capacity.
Jones said, "One of the things we see our start-ups spending a lot of time thinking through, is what is the most efficient form of capital that I should be working with, or the best form of capital.
"Is it the reciprocal model, is it traditional reinsurance, is it having their own carrier. You know, is it doing something using derivatives in Bermuda, for example. For each start-up there's going to be an ideal answer, I think."